Cognitive impairment in neurofibromatosis type 1

American Journal of Medical Genetics - Seminars in Medical Genetics

Volumn 89, Issue 1, 1999, Pages 45-52

  Ozonoff, Sally ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

Cognitive function; Learning disabilities; Neuropsychology; NF1

Indexed keywords

ARTICLE; BEHAVIOR DISORDER; COGNITIVE DEFECT; DISEASE ASSOCIATION; HUMAN; INTELLIGENCE QUOTIENT; LEARNING DISORDER; MENTAL DEFICIENCY; NEUROFIBROMATOSIS; NEUROPSYCHOLOGY; PHENOTYPE; PRIORITY JOURNAL;

COGNITION DISORDERS; HUMANS; INTELLIGENCE; LANGUAGE; MENTAL RETARDATION; NEUROFIBROMATOSIS 1; NEUROPSYCHOLOGICAL TESTS;

EID: 0033605451     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19990326)89:1<45::AID-AJMG9>3.0.CO;2-J     Document Type: Article

References (51)

1. Anderson BW. 1992. Comorbidity of attention deficit hyperactivity disorder and NF1. Am J Psychiatry 149:148-149.
2. Bawden H, Dooley J, Buckley D, Camfield P, Gordon K, Riding M, Llewellyn G. 1996. MRI and nonverbal cognitive deficits in children with neurofibromatosis 1. J Clin Exp Neuropsychol 18:784-792.
3. Chapman CA, Waber DP, Bassett N, Urion DK, Korf BR. 1996. Neurobehavioral profiles of children with neurofibromatosis 1 referred for learning disabilities are sex-specific. Am J Med Genet 67:127-132.
4. Chelune GJ, Ferguson W, Koon R, Dickey TO. 1986. Frontal lobe disinhibition in attention deficit disorder. Child Psychiatry Hum Dev 16:221-234.
5. Cole WG, Myer NA. 1978. Neurofibromatosis in childhood. Aust N Z J Surg 48:360-365.
6. Crowe FW, Schull WJ, Neel JV. 1956. A clinical, pathological and genetic study of multiple neurofibromatosis. Springfield Ill.: Charles C Thomas. 181 p.
7. Denckla MB, Hofman K, Mazzocco MMM, Melhem E, Reiss AL, Bryan RN, Harris EL, Lee J, Cox CS, Schuerholz LJ. 1996. Relationship between T2-weighted hyperintensities (unidentified bright objects) and lower IQs in children with neurofibromatosis 1. Am J Med Genet 67:98-102.
8. Denckla MB, Reader MJ. 1993. Education and psychosocial interventions: executive dysfunction and its consequences. In: Kurlan R, editor. Handbook of Tourette's syndrome and related tic and behavioral disorders. New York: Marcel Dekker. p 431-451.
9. Diamond A, Ciaramitaro V, Donner E, Hurwitz W, Lee E, Grover W, Minarcik C. 1992. Prefrontal cortex cognitive deficits in early-treated PKU: results of a longitudinal study in children and of an animal model. Soc Neurosci Abstr 18:1063.
10. Dilts CV, Carey JC, Kircher JC, Hoffman RO, Creel D, Ward K, Clark E, Leonard CO. 1996. Children and adolescents with neurofibromatosis 1: a behavioral phenotype. Dev Behav Pediatr 17:229-239.
11. Duffner PK, Cohen ME, Seidel FG, Shucard DW. 1989. The significance of MRI abnormalities in children with neurofibromatosis. Neurology 39:373-378.
12. Duncan J. 1986. Disorganization of behaviour after frontal lobe damage. Cogn Neurol 3: 271-290.
13. Dunn DW, Roos KL. 1989. Magnetic resonance imaging evaluation of learning difficulties and motor incoordination in neurofibromatosis. Neurofibromatosis 2:1-5.
14. Eldridge R, Denckla MB, Bien E, Myers S, Kaiser-Kupfer MI, Pikus A, Schlesinger SL, Parry DM, Dambrosia JM, Zasloff MA, Mulvihill JJ. 1989. Neurofibromatosis type 1 (Recklinghausen's disease): neurologic and cognitive assessment with sibling controls. Am J Dis Child 143:833-837.
15. Eliason MJ. 1986. Neurofibromatosis: implications for learning and behavior. Dev Behav Pediatr 7:175-179.
16. Ferner RE, Chaudhuri R, Bingham J, Cox T, Hughes RAC. 1993. MRI in neurofibromatosis 1: the nature and evolution of increased intensity T2 weighted lesions and their relationship to intellectual impairment. J Neurol Neurosurg Psychiatry 56:492-495.
17. Ferner RE, Hughes RAC, Weinman J. 1996. Intellectual impairment in neurofibromatosis 1. J Neurol Sci 138:125-133.
18. Frangiskakis JM, Ewart AK, Morris CA, Mervis CB, Bertrand J, Robinson BF, Klein BP, Ensing GJ, Everett LA, Green ED, Proschel C, Gutowski N, Noble M, Atkinson DL, Odelberg SJ, Keating MT. 1996. LIM-kinase 1 hemizygosity implicated in impaired visuospatial constructive cognition. Cell 86:59-69.
19. Gillberg C, Forsell C. 1984. Childhood psychosis and neurofibromatosis: more than a coincidence? J Autism Dev Disord 14:1-8.
20. Harnadek MCS, Rourke BP. 1994. Principal identifying features of the syndrome of non-verbal learning disabilities in children. J Learn Disabil 27:144-154.
21. Hodapp RM, Dykens EM, Hagerman RJ, Schreiner R, Lachiewicz AM, Leckman JF. 1990. Developmental implications of changing trajectories of IQ in males with fragile X syndrome. J Am Acad Child Adolesc Psychiatry 29:214-219.
22. Hofman KJ, Harris EL, Bryan RN, Denckla MB. 1994. Neurofibromatosis type 1: the cognitive phenotype. J Pediatr (Suppl) 124:S1-S8.
23. Itoh T, Magnaldi S, White RM. 1994. Neurofibromatosis type 1: the evolution of deep gray and white matter MR abnormalities. Am J Neuroradiol 15:1513-1519.
24. Joy P, Roberts C, North K, deSilva M. 1995. Neuropsychological function and MRI abnormalities in neurofibromatosis type 1. Dev Med Child Neurol 37:906-914.
25. Legius E, Descheemaeker MJ, Spaepen A, Casaer P, Fryns JP. 1994. Neurofibromatosis type 1 in childhood: a study of the neuropsychological profile in 45 children. Genetic Couns 5:51-60.
26. Legius E, Descheemaeker MJ, Steyaert J, Spaepen A, Vlietinck R, Casaer P, Demaerel P, Fryns JP. 1995. Neurofibromatosis type 1 in childhood: correlation of MRI findings with intelligence. J Neurol Neurosurg Psychiatry 59:638-640.
27. Luria AR. 1966. The higher cortical functions in man. New York: Basic Books.
28. Mateer CA, Williams D. 1991. Effects of frontal lobe injury in childhood. Special issue: developmental consequences of early frontal lobe damage. Dev Neurosci 7:359-376.
29. Mazzocco MMM, Hagerman RJ, Cronister-Silverman A, Pennington BF. 1992. Specific frontal lobe deficits among women with the fragile X gene. J Am Acad Child Adolesc Psychiatry 31:1141-1148.
30. Mazzocco MMM, Pennington BF, Hagerman RJ. 1993. The neurocognitive phenotype of female carriers of fragile X: additional evidence for specificity. J Dev Behav Pediatr 14:328-335.
31. Mazzocco MMM, Turner JE, Denckla MB, Hofman KJ, Scanlon DC, Vellutino FR. 1995. Language and reading deficits associated with NF1: evidence for not-so-nonverbal learning disability. Dev Neurosci 11:503-522.
32. Merenstein SA, Sobesky WE, Taylor AK, Riddle JE, Tran HX, Hagerman RJ. 1996. Molecular-clinical correlations in males with an expanded FMR1 mutation. Am J Med Genet 64:388-394.
33. Moore BD, Ater JL, Needle MN, Slopis J, Copeland DR. 1994. Neuropsychological profile of children with neurofibromatosis, brain tumor, or both. J Child Neurol 9:368-377.
34. Moore BD, Slopis JM, Schomer D, Jackson EF, Levy BM. 1996. Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis. Neurology 46:1660-1668.
35. Mouridsen SE, Andersen LB, Sorensen SA, Rich B, Isager T. 1992. Neurofibromatosis in infantile autism and other types of childhood psychoses. Acta Paedopsychiatr 55:15-18.
36. Mouridsen SE, Sorensen SA. 1995. Psychological aspects of von Recklinghausen neurofibromatosis (NF1). J Med Genet 32:921-924.
37. North K, Joy P, Yuille D, Cocks N, Hutchins P. 1995. Cognitive function and academic performance in children with neurofibromatosis type 1. Dev Med Child Neurol 37: 427-436.
38. North K, Joy P, Yuille D, Cocks N, Mobbs E, Hutchins P, McHugh K, deSilva M. 1994. Specific learning disability in children with neurofibromatosis type 1: significance of MRI abnormalities. Neurology 44:878-883.
39. North KN, Riccardi V, Samango-Sprouse C, Ferner R, Moore B, Legius E, Ratner N, Denckla MB. 1997. Cognitive function and academic performance in neurofibromatosis 1: consensus statement from the NF1 cognitive disorders task force. Neurology 48: 1121-1127.
40. Ozonoff S. 1998. Assessment and remediation of executive dysfunction in autism and Asperger syndrome. In: Schopler E, Mesibov GB, editors. Asperger syndrome or high-functioning autism? New York: Plenum. p 263-289.
41. Pennington BF. 1991. Diagnosing learning disorders: a neuropsychological framework. New York: Guilford.
42. Pennington BF, Ozonoff S. 1996. Executive functions and developmental psychopathologies. J Child Psychol Psychiatry 37: 51-87.
43. Rutter M, Bailey A, Bolton P, LeCouter A. 1994. Autism and known medical conditions: myth and substance. J Child Psychol Psychiatry 35:311-322.
44. Sattler JM. 1992. Assessment of children, 3rd rev. ed. San Diego: Sattler Publishing.
45. Silva AJ, Frankland PW, Marowitz Z, Friedman E, Lazlo G, Cioffi D, Jacks T, Bourtchuladze R. 1997. A mouse model for the learning and memory deficits associated with neurofibromatosis type 1. Nature Genet 15:281-284.
46. Stine SB, Adams WV. 1989. Learning problems in neurofibromatosis patients. Clin Orthop 245:43-48.
47. Stuss DT, Benson DF. 1984. Neuropsychological studies of the frontal lobes. Psychiatr Bull 95:3-28.
48. Wadsby M, Lindehammar H, Eeg-Olofsson O. 1989. Neurofibromatosis in childhood: neuropsychological aspects. Neurofibromatosis 2:251-260.
49. Welsh MC, Pennington BF, Ozonoff S, Rouse B, McCabe ERB. 1990. Neuropsychology of early-treated phenylketonuria: specific executive function deficits. Child Dev 61: 1697-1713.
50. Williams PG, Hersh JH. The association of neurofibromatosis type 1 and autism. J Autism Dev Disord 28:567-571.
51. Zoller MET, Rembeck B, Backman L. 1997. Neuropsychological deficits in adults with neurofibromatosis type 1. Acta Neurol Scand 95:225-232.